Table 3.
Antimicrobial resistance pattern of E. coli and K. pneumoniae isolates from Hospital-acquired and Community-acquired urinary tract infections (% of resistance isolates within each group)
| Antibiotic | E. coli (n = 110) | K. pneumoniae (n = 27) | ||||||
|---|---|---|---|---|---|---|---|---|
| Hospital acquired | Community acquired | Hospital acquired | Community acquired | |||||
| ESBL (+) (n = 11) |
ESBL (−) (n = 43) |
ESBL (+) (n = 4) |
ESBL (−) (n = 52) |
ESBL (+) (n = 4) |
ESBL (−) (n = 8) |
ESBL (+) (n = 5) |
ESBL (−) (n = 10) |
|
| AMC | NA | 11.6 | NA | 17.3 | NA | 62.5 | NA | 30.0 |
| CTX | NA | 0 | NA | 0 | NA | 0 | NA | 0 |
| CTZ | NA | 0 | NA | 0 | NA | 0 | NA | 0 |
| CRO | NA | 0 | NA | 0 | NA | 0 | NA | 0 |
| IMP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CHL | 27.3 | 41.9 | 25.0 | 34.6 | 75.0 | 62.5 | 100 | 40.0 |
| CIP | 90.9 | 32.6 | 75.0 | 23.1 | 100 | 25.0 | 40.0 | 20.0 |
| DOX | 100 | 69.8 | 100 | 76.9 | 75.0 | 62.5 | 60.0 | 30.0 |
| CN | 90.9 | 16.3 | 50.0 | 21.2 | 100 | 37.5 | 80.0 | 10.0 |
| NAL | 90.0 | 41.9 | 75.0 | 34.6 | 100 | 25.0 | 40.0 | 30.0 |
| NIT | 27.3 | 27.3 | 50.0 | 50.0 | 100 | 100 | 60.0 | 60.0 |
| SXT | 90.9 | 62.8 | 100 | 80.8 | 75.0 | 87.5 | 60.0 | 60.0 |
(+) = positive; (−) = negative
AMC Amoxicillin-clavulanic acid, CTX cefotaxime, CTZ ceftazidime, CRO ceftriaxone, IMP imipenem, CHL chloramphenicol, CIP ciprofloxacin, DO doxycycline, CN gentamicin, NAL nalidixic acid, NIT nitrofurantoin, SXT trimethoprim-sulfamethoxazole